Subject: Biotech Research Products To Be Marketed by Du Pont
Date: Published: 10/29/84 30 lines
Source:  Wall Street Journal.  Copyright Dow Jones Inc. 

   Biotech Research Products
   To Be Marketed by Du Pont

   ROCKVILLE, Md. -- Biotech Research Laboratories Inc. said
Du Pont Co. agreed to market all of Biotech's monoclonal
antibodies and various viral diagnostic products.
   The agreement gives Du Pont exclusive world-wide marketing
rights for Biotech's products, except in Japan, Australia and
New Zealand, where there are previous agreements.
   Du Pont also will have the first option to market new
products developed by Biotech, which makes diagnostic kits
for certain diseases and monoclonal antibodies, which are
used in vaccines and research.
   In June, the two companies were licensed by the federal
government to develop and produce a test kit to detect
antibodies to a virus associated with acquired immune
deficiency syndrome, or AIDS. 
   The companies also agreed in July to a financing and
research and development arrangement in which Du Pont
purchased a 7% equity interest in Biotech, to be accomplished
in two phases, Biotech said.

[This article is made available here by Dow Jones Co. for the 
personal and non-commercial use of callers to this bbs, in the 
hope that it will be of some help to those who are suffering 
from the disease and others who are seeking to help them.]